▽everolimus myelofibrosis - PubMed - NCBI ●01/04 09:42 2025 0Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update.Roskoski R Jr. Roskoski R Jr. Pharmacol Res. 2020 Feb;152:104609. doi: 10.1016/j.phrs.2019.104609. Epub 2019 Dec 17. Pharmacol Res. 2020. PMID: 31862477 Review.Fedratinib blocks JAK2 and is used in the treatment of myelofibrosis. Overall, the US FDA has approved 52 small molecule protein kinase inhibitors,
▽CPX-351 - PubMed - NCBI ●01/04 02:59 2025 2CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis.Renga G, Nunzi E, Stincardini C, Pariano M, Puccetti M, Pieraccini G, Di Serio C, Fraziano M, Poerio N, Oikonomou V, Mosci P, Garaci E, Fianchi L, Pagano L, Romani L. Renga G, et al. Blood. 2024 Apr 18;143(16):1628-1645. doi: 10.1182/blood.2023021380. Blood. 2024. PMID:
